Active TopicsActive Topics  Display List of Forum MembersMemberlist  CalendarCalendar  Search The ForumSearch  HelpHelp
  RegisterRegister  LoginLogin

Emerging companies - Mid caps that can become large cap
 The Equity Desk Forum :Investment Ideas - Creating winning portfolios! :Emerging companies - Mid caps that can become large cap
Message Icon Topic: Vimta Lab-Contract research will drive growth here Post Reply Post New Topic
<< Prev Page  of 9 Next >>
Author Message
reetesh
Senior Member
Senior Member
Avatar

Joined: 01/Sep/2006
Location: India
Online Status: Offline
Posts: 793
Quote reetesh Replybullet Posted: 05/Sep/2006 at 11:40am
Originally posted by reetesh

It look as if provoked Vimta Lab.. Some loved your report.
When going gets tough, that’s when tough (people) gets going.
IP IP Logged
prashant
Newbie
Newbie
Avatar

Joined: 13/Sep/2006
Location: India
Online Status: Offline
Posts: 33
Quote prashant Replybullet Posted: 06/Nov/2006 at 12:31pm

Hi,

Thought I will add my few cents on Clinical Research space. It can be broadly divided into two areas

1. Contract research - where the firm tries to discover new drug molecule on a contract basis. A very high value added function, that can give high returns but can have a high failure rate as well

2. Clinical trials - where a firm will carry out clinical trials ( phase I to phase IV) for a large pharma co. These trials can run upto 7-12 years.Here the business processes involved are

 - Locating sites ( hospitals ) for clinical trials

- Recruitment of investigators ( doctors) and volunteers for the trials.

- Project management of clinical trials, managing the regulatory procedures

- Data management

Clinical trials are manpower intensive areas where quantum of revenue is assured, but per person revenus is lower than contract research. Cost of conducting a clinical trial can be anywhere between a few million to hundred million dollars. Thus Clinical researcg cos. have a fairly good revenue+ profitability worldwide.

Contract research as well clinical trial projects are coming to India primarily due to
 
1. Lower cost of conducting clinical trials ( cost is upto 30-40% lower than in West)
2. Availability of knowledgeable PHDs and science grads.
3. Availability of large patient population ( non anglo saxon ) to study effects of new drugs.
 
 
Thus going forward, it will be another IT /ITES like sunrise field for Indian companies who have well trained staff,stringent Quality focus, good market reputation and most important, US FDA approved facilities.
 
In terms of competition, there are many big names such as ERT, Quintiles, Covance, etc either already in India or setting up their shops. These are big multinationals, have deep pockets and tons of experience in dealing with all major multinationals as well as FDA.
 
From whatever I read on Vimta Labs, they are trying to enter both the areas. Thus going forward they can have a fairly good opportunities available.However they will have to deal with the competition from the above mentioned players and a few Indian cos. present.

Hope you find it useful.

Prashant
IP IP Logged
omshivaya
Senior Member
Senior Member
Avatar

Joined: 06/Sep/2006
Location: India
Online Status: Offline
Posts: 5966
Quote omshivaya Replybullet Posted: 06/Nov/2006 at 8:30pm
"The company ahs a vision statement to be among the top 10 global research and Contract Company by 2010"
 
 
Basant ji,
What is the approximate revenue of the 10th global player in this area? Just wanted to know what Vimta is targeting?
 
Thanks and just a rough idea would do.
The most important quality for an investor is temperament,not intellect.A temperament that neither derives great pleasure from being with the crowd nor against it
IP IP Logged
basant
Admin Group
Admin Group
Avatar

Joined: 01/Jan/2006
Location: India
Online Status: Offline
Posts: 18403
Quote basant Replybullet Posted: 06/Nov/2006 at 8:39pm
At least more then US $ 500 million - This is a wild guess though people working in this industry should be able to provide a more reliable guess.
'The Thoughtful Investor: A Journey to Financial Freedom Through Stock Market Investing' - A Book on Equity Investing especially for Indian Investors. Book your copy now: www.thethoughtfulinvestor.in
IP IP Logged
omshivaya
Senior Member
Senior Member
Avatar

Joined: 06/Sep/2006
Location: India
Online Status: Offline
Posts: 5966
Quote omshivaya Replybullet Posted: 06/Nov/2006 at 8:42pm
So, they are targeting something like 2200 crores and are now around 100 crores(approx.).
By the way who is the leader in India for CRAM? Vimta?
The most important quality for an investor is temperament,not intellect.A temperament that neither derives great pleasure from being with the crowd nor against it
IP IP Logged
omshivaya
Senior Member
Senior Member
Avatar

Joined: 06/Sep/2006
Location: India
Online Status: Offline
Posts: 5966
Quote omshivaya Replybullet Posted: 06/Nov/2006 at 9:43pm
Basant ji, your gut feeling on this one? 2200 crores target by 2010-11 and right now around 100 crores(assumtpion). It means a 20 times revenues generation in next 3-4 years?
 
 
What do you know of this one or feel on this one? We talk of Pantaloons and TV18 but I dont see so much of your passion for this one? That is why I am asking what do you feel on Vimta? Is it the leader in India in its industry(which is CRAM I suppose)?
 
 
Please put in a detailed view kindly. Really would be thankful for the same.
The most important quality for an investor is temperament,not intellect.A temperament that neither derives great pleasure from being with the crowd nor against it
IP IP Logged
basant
Admin Group
Admin Group
Avatar

Joined: 01/Jan/2006
Location: India
Online Status: Offline
Posts: 18403
Quote basant Replybullet Posted: 06/Nov/2006 at 10:02pm
I do not understand these companie that is why I do not comment/write (invest) but if we could have some one who knows what this business is doing then Vimta is a potential multibagger no doubt.
'The Thoughtful Investor: A Journey to Financial Freedom Through Stock Market Investing' - A Book on Equity Investing especially for Indian Investors. Book your copy now: www.thethoughtfulinvestor.in
IP IP Logged
omshivaya
Senior Member
Senior Member
Avatar

Joined: 06/Sep/2006
Location: India
Online Status: Offline
Posts: 5966
Quote omshivaya Replybullet Posted: 06/Nov/2006 at 10:13pm

Basant ji,

 
Vimta Labs is targeting 100 mill US$ by 2010 so the 10th player has to have a revenue around 100 mill. I did a lot of search on google and have found a link to an article by Vimta which points where they plan to be. It also gives a lot of details and hence will be helpful to you too to analyze it.
 
 
 
It was written in early 2006 so stll relatively fresh stuff. At 100 mill US$, we have a 40-50% CAGR for next 3-4 years or maybe a bit more.
The most important quality for an investor is temperament,not intellect.A temperament that neither derives great pleasure from being with the crowd nor against it
IP IP Logged
<< Prev Page  of 9 Next >>
Post Reply Post New Topic
Printable version Printable version

Forum Jump
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot delete your posts in this forum
You cannot edit your posts in this forum
You cannot create polls in this forum
You cannot vote in polls in this forum



This page was generated in 0.062 seconds.
Bookmark this Page